
In this article, I have evaluated leading medical stocks AbbVie Inc. (ABBV) and Pfizer Inc. (PFE) to analyze which stock is the better buy. After thoroughly evaluating these stocks, I think ABBV might be the right pick for the reasons discussed in this article.
The pharmaceutical landscape has undergone a massive transformation with the emergence of new technologies and cost-effective and more efficient manufacturing approaches. In addition, increasing investment flow in this space is expected to impact the market growth positively.